Giuseppe Lopalco Selected Research

Biological Therapy

1/2023	Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry.
11/2020	Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study.
1/2020	New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy.
1/2019	Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.
1/2018	Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study.
1/2018	Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.
5/2016	Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy.
7/2015	Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Lopalco Research Topics

Disease

23	Uveitis 05/2024 - 01/2015
18	Rheumatoid Arthritis 01/2024 - 10/2014
10	Inflammation (Inflammations) 12/2023 - 09/2014
9	Fever (Fevers) 11/2023 - 01/2014
8	Vasculitis (Vasculitides) 12/2023 - 06/2016
8	Psoriatic Arthritis 05/2023 - 01/2016
8	Adult-Onset Still's Disease 12/2022 - 05/2016
8	Behcet Syndrome (Behcet's Syndrome) 11/2020 - 10/2015
6	Pericarditis 01/2022 - 01/2015
6	Necrosis 07/2020 - 06/2015
5	Axial Spondyloarthritis 12/2023 - 07/2018
5	Arthritis (Polyarthritis) 11/2023 - 09/2016
5	Infections 03/2023 - 07/2015
4	Retinal Vasculitis 05/2024 - 01/2017
4	Anterior Uveitis 08/2023 - 11/2016
4	autosomal dominant familial Periodic fever 01/2021 - 09/2014
4	Ankylosing Spondylitis 09/2019 - 11/2016
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019 - 05/2016
3	Churg-Strauss Syndrome (Allergic Angiitis) 12/2023 - 01/2022
3	Lymphadenopathy 11/2023 - 01/2015
3	Panuveitis 08/2023 - 01/2019
3	Hepatitis B 03/2022 - 07/2015
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 10/2019
3	Exanthema (Rash) 01/2020 - 01/2019
3	Acquired Immunodeficiency Syndrome (AIDS) 04/2019 - 01/2015
3	Macular Edema 01/2019 - 01/2017
2	Myocarditis (Carditis) 12/2023 - 01/2018
2	Pneumonia (Pneumonitis) 11/2023 - 01/2020
2	Posterior Uveitis 08/2023 - 02/2019
2	Intermediate Uveitis (Chronic Cyclitis) 08/2023 - 02/2019
2	Myositis (Idiopathic Inflammatory Myopathies) 03/2023 - 09/2016
2	Rheumatic Diseases (Rheumatism) 01/2023 - 01/2022
2	Joint Diseases (Joint Disease) 01/2023 - 11/2018
2	Polymyositis 10/2022 - 01/2017
2	Serositis 01/2022 - 01/2021
2	Proteinuria 01/2021 - 01/2020
2	Scleritis (Episcleritis) 11/2020 - 01/2020
2	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 09/2016 - 10/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2016 - 01/2015
2	Obesity 05/2016 - 12/2015
2	Gout 05/2016 - 01/2015
1	Blindness (Hysterical Blindness) 03/2024
1	Colorectal Neoplasms (Colorectal Cancer) 01/2024

Drug/Important Bio-Agent (IBA)

19	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2023 - 04/2015
14	Interleukin-1 (Interleukin 1)IBA 01/2021 - 09/2014
12	InterleukinsIBA 12/2023 - 01/2015
12	Adalimumab (Humira)FDA Link 08/2023 - 01/2016
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2020 - 01/2014
10	CytokinesIBA 07/2020 - 01/2014
9	Antirheumatic Agents (DMARD)IBA 01/2024 - 01/2016
9	Infliximab (Remicade)FDA Link 07/2020 - 06/2015
9	canakinumab FDA Link 01/2020 - 04/2015
8	C-Reactive ProteinIBA 12/2023 - 07/2018
7	Tumor Necrosis Factor InhibitorsIBA 08/2023 - 11/2016
7	Rituximab (Mabthera)FDA Link 03/2023 - 07/2015
7	SteroidsIBA 01/2023 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2015
6	Colchicine FDA LinkGeneric 01/2023 - 01/2018
6	tocilizumab (atlizumab)FDA Link 12/2022 - 05/2016
6	Etanercept (Enbrel)FDA Link 06/2020 - 09/2014
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 09/2014
5	Fluorescein (Funduscein)FDA LinkGeneric 03/2024 - 01/2017
5	Monoclonal AntibodiesIBA 03/2023 - 06/2015
5	InflammasomesIBA 01/2023 - 01/2015
5	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 01/2018
4	secukinumabIBA 01/2022 - 07/2018
3	HLA Antigens (Human Leukocyte Antigens)IBA 05/2024 - 12/2023
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 12/2023 - 09/2019
3	GlucocorticoidsIBA 08/2023 - 11/2020
3	BNT162 VaccineIBA 01/2023 - 01/2022
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021 - 10/2015
3	AntibodiesIBA 07/2020 - 09/2016
3	baricitinibIBA 01/2020 - 01/2019
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 01/2015
2	Prednisone (Sone)FDA LinkGeneric 12/2023 - 01/2022
2	Anti-Citrullinated Protein AntibodiesIBA 11/2023 - 05/2016
2	Rheumatoid FactorIBA 11/2023 - 05/2016
2	Ferritins (Ferritin)IBA 11/2023 - 11/2023
2	Immunosuppressive Agents (Immunosuppressants)IBA 08/2023 - 08/2018
2	Immunoglobulin G (IgG)IBA 03/2023 - 01/2023
2	mepolizumabIBA 12/2022 - 01/2022
2	Ligases (Synthetase)IBA 10/2022 - 09/2016
2	Biosimilar PharmaceuticalsIBA 09/2021 - 01/2019
2	golimumab FDA Link 01/2021 - 07/2019
2	Prostaglandins AIBA 11/2020 - 01/2020
2	CholesterolIBA 01/2020 - 01/2020
2	Abatacept (Orencia)FDA Link 01/2020 - 05/2016
2	Certolizumab Pegol FDA Link 07/2019 - 11/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2017 - 01/2017
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 07/2015
2	Transaminases (Aminotransferases)IBA 01/2017 - 07/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2015
2	AutoantibodiesIBA 10/2015 - 01/2014
1	HLA-B Antigens (HLA-B)IBA 05/2024
1	HLA-B51 AntigenIBA 05/2024
1	Troponin T (Troponin T1)IBA 12/2023
1	pro-brain natriuretic peptide (1-76)IBA 12/2023

Therapy/Procedure

18	Therapeutics 12/2023 - 04/2015
8	Biological Therapy 01/2023 - 07/2015
2	Duration of Therapy 01/2019 - 06/2018